The global Obesity Surgery Devices market accounted for USD 2.43 Billion in 2020 and is expected to reach USD 4.02 Billion by 2028, growing at a CAGR of around 6.2% between 2021 and 2028.
The global Obesity Surgery Devices market accounted for USD 2.43 Billion in 2020 and is expected to reach USD 4.02 Billion by 2028, growing at a CAGR of around 6.2% between 2021 and 2028.
The global obesity surgery devices market is majorly boosted by the increasing prevalence of obesity everywhere in the world. Other major boosting factors of the obesity surgery devices market are growing awareness about obesity-associated complexities and the rising occurrence of obesity-related chronic diseases. On the opposite hand, lower disposable revenues and therefore the high price of surgeries are the main limitation which may hinder the event of the obesity surgery devices market.
Nevertheless, government initiatives to prevent obesity paired with an enormous investment in obesity surgery devices everywhere on the planet are expected to reveal new growth opportunities within the near future for the obesity surgery devices market. Rising initiatives by market players are additionally one among the explanations that are liable for the development of the obesity surgery devices market. for instance, in April 2018, MID arranged for XXIIIrd World Congress IFSO International Federation for the surgery of metabolic & obesity disorders, thus powering the obesity surgery devices market.
COVID-19 Impact Analysis
Besides, the COVID-19 outbreak, there's a drastic rise in the demand for medical facilities across the world. The increasing corona cases across the world are forcing governments of developed and emerging countries to extend their patient handling and increase surgery capacities which have been delayed due to pandemics. Several governments are proposing obesity awareness initiatives and taking various action plans to curb obesity. Governments also are encouraging non-invasive obesity surgeries to stop infection cases.
Growth Factors
The global Obesity Surgery Devices market is propelled owing to the increasing obesity among children and adults everywhere in the world which has become a significant health issue. Also, adults are more apt to numerous persistent diseases. This remains a key factor fueling the demand for obesity surgery devices within the global market. Rising inclination towards a sedentary lifestyle and burgeoning frequency of consuming food is the foremost likely to spice up obesity, and eventually the marketplace for obesity surgery devices. Increasing awareness among overweight people in developing regions about the potential ill effects of obesity, including diabetes, CVDs, and stroke is predicted to drive the obesity surgery devices market. Also, the increasing availability of surgical treatments for reducing excess weight is additionally anticipated to support the market growth.
Report Scope:
Segment Analysis Preview
The obesity surgery devices market is divided based on various surgical procedures like sleeve gastrectomy surgery, gastric bypass surgery, and others including gastric banding surgery. The gastric bypass surgery sector in the obesity surgery devices market holds utmost share and can keep it up to try to so within the coming years. Whereas, sleeve gastrectomy is foreseen to witness the fastest growth during the forecast period 2021-2028. Based on device type, the obesity surgery devices market is bifurcated into intragastric balloons, adjustable gastric bands, surgical staples, clip appliers, and others including trocars.
Regional Analysis Preview
North America is probably going to remain the leading area within the obesity surgery devices market followed by Europe over the forecast period. Requirement for obesity surgery devices was uppermost in North America particularly within the U.S. Asia Pacific is probably going to be the reasonable developing area during the forecast period in the obesity surgery devices market. Furthermore, Latin America and therefore the MEA also are likely to point out reasonable development for the obesity surgery devices market within the coming years.
Key Market Players & Competitive Landscape
The major players that are comprised in the Obesity Surgery Devices market are Medtronic, Inc., Allergan, Inc., Cousin Biotech, EnteroMedics, Inc., Mediflex Surgical Products, Johnson & Johnson, Aspire Bariatrics, TransEnterix Inc., and Spatz FGIA Inc. among others. These players are set to bolster the development of obesity surgery devices market.
By Device Type
By Surgery Procedure
By Region
FrequentlyAsked Questions
The global Obesity Surgery Devices Market was valued at USD 2.43 billion in 2020.
The global Obesity Surgery Devices Market is expected to reach USD 4.02 billion by 2028, growing at a CAGR of 6.2% between 2021 to 2028.
Factors such as the increasing incidence of obesity, growth in the elderly population, healthcare infrastructure improvements, and the increasing prevalence of chronic diseases are the major factors driving the market growth.
North America in 2020 ruled the Obesity Surgery Devices market and was believed to be the highest income-generating area all over the globe.
The major players that are comprised in Obesity Surgery Devices market are Medtronic, Inc., Allergan, Inc., Cousin Biotech, EnteroMedics, Inc., Mediflex Surgical Products, Johnson & Johnson, Aspire Bariatrics, TransEnterix Inc., and Spatz FGIA Inc. among others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed